“With Helix, we get clinical-grade genomic data and a turnkey platform to enable clinical and research insights, giving us the flexibility to build the initiative that is right for our patients, providers, and researchers. They are fantastic partners in an ambitious population health study.”

Joseph Grzymski, Ph.D.

Principal Investigator, Healthy Nevada Project
Chief Scientific Officer, Renown Health

Health system leaders today are constantly balancing competing priorities and searching for efficient solutions to achieve ambitious strategic goals:

Improve
population health

Enhance the
patient experience

Increase provider satisfaction

Reduce the
cost of care

As more targeted, personalized and efficient care is pursued, it is critical to properly stratify the major healthcare risks that threaten communities. Genomics presents an opportunity to address population health challenges while driving service line growth.

Population Genomics with Helix

Driven by the Sequence Once, Query OftenTM model, population genomics with Helix allows health systems to uncover genetic risk more efficiently and utilize genetic insights at the point-of-care. Leading health systems have seen these programs improve care, address health inequities and engage patients & providers, all while reducing costs.

Improve clinical outcomes through earlier and more appropriate monitoring & treatment

Decrease costs from early identification and intervention for at-risk patients

Create a roadmap for innovation with accelerated genetic research and industry collaborations

How It Works

The success of these programs has been driven by Helix’s end-to-end platform, expertise in workflow integration and our strategic partnering approach. We provide holistic support throughout your entire implementation.

Icon arrow right
Fill 13

Recruitment
& engagement

Fill 19

Enrollment
& Collection

Fill 11

Sequencing
& Interpretation

Fill 15

Return
of Results

Group 18

Sequence Once,
Query OftenTM

Group 19

Research
& Analytics

What is Sequence Once, Query OftenTM?

The genetics you inherit is the only data set in healthcare that doesn’t change over time, which is why, if you generate high enough quality sequencing data you should be able to use that data again and again both in the care of the patient and for research purposes. Because of this, we deploy a Sequence Once, Query OftenTM model, in which patients are comprehensively sequenced just once with our Exome+ assay, creating a lifelong digital genomic resource and enabling point-of-care access to a wealth of clinical genetic insights to improve patient care.

First test
Sample collection +
sequencing

First test
Sample collection +
sequencing

One sample

Subsequent tests
On-demand queries
(software only)

Subsequent tests
On-demand queries
(software only)

CDC Tier 1

Pharmaco-
Genomics

Cancer
Screening

Cardiovascular
Panel

73-Gene Panel

Carrier
Screening

Group 19

Research

First test
Sample collection +
sequencing

Subsequent tests
On-demand queries
(software only)

CDC Tier 1

Pharmaco-
Genomics

Cancer
Screening

Cardiovascular
Panel

73-Gene Panel

Carrier
Screening

Group 19

Population Genomics in Action: The Healthy Nevada Project

Led by Renown Health

• A locally governed & owned, not-for-profit integrated healthcare network

• Serving 500,000 individuals

• 100,000 square mile reach

The Challenge

• Nevada ranked poorly (48th) when it came to overall measures of population health

• Renown wanted to utilize genetics & other data to understand key drivers of poor outcomes for the community

• Engaging the community in preventative care while reducing costs was critical to Renown’s strategy

The Results

Within one year, Renown was able to see the impact of their population genomics program and the change in the standard of care in their community.

Strong Patient Engagement

25,000

People enrolled, sequenced, and given results in the first 6 months

Of non-Renown patients had
their first visit within 6 months

Measurable Clinical Impact

1 in 75

Participants were identified as at-risk for at least one serious, actionable genetic condition

Of those patients that were found to be at-risk would not have been detected in standard clinical care

Partnering with Helix

Helix has partnered with a number of leading health systems around the nation. Learn more about how we're partnering with one organization in the video below.

Learn more about our partners

Get in touch

To learn more about implementing a population genomics program, complete this form and we’ll be in touch soon.
If you have questions about your COVID-19 test result, please email support@helix.com

Exciting!

This could be the beginning of something big. A member of our team will send you a welcome email soon.

*Required fields